This paper reviews the scientific knowledge about protein-energy and micronutrient malnutrition in the context of Chagas disease, especially in experimental models. The search of articles was conducted using the electronic databases of SciELO (Scientific Electronic Library Online), PubMed and MEDLINE published between 1960 and March 2010. It was possible to verify that nutritional deficiencies (protein-energy malnutrition and micronutrient malnutrition) exert a direct effect on the infection by T. cruzi. However, little is known about the immunological mechanisms involved in the relationship “nutritional deficiencies and infection by T. cruzi”. A hundred years after the discovery of Chagas disease many aspects of this illness still require clarification, including the effects of nutritional deficiencies on immune and pathological mechanisms of T. cruzi infection. 1. Introduction The protein-energy malnutrition (PEM) and micronutrient malnutrition (MNM) are common problems worldwide and occur in both developing and developed nations. In the developing world, it is a reflection of socioeconomic, political, or environmental factors, and, in developing countries, PEM usually occurs in the context of chronic diseases [1]. Chagas disease is a chronic parasite illness caused by the hemoflagellate protozoan Trypanosoma cruzi, affecting millions of people in developing nations in the South and Central Americas. It is estimated that 15-16 million people are infected with T. cruzi in Latin America and 75–90 million are at risk of infection [2]. Due the prevalence of Chagas disease and PEM-MNM together, they are, directly or indirectly, responsible for millions of deaths worldwide [3, 4]. PEM is a major public health problem in the tropical and subtropical regions of the world and often arises during protein and/or energy deficit due to nutritional inadequacy, infections, and poor socioeconomic and environmental conditions [3]. It is the most common nutritional disorder affecting children in developing countries and the third most common clinical disorder of childhood in such countries. PEM has a lasting effect on immune functions, growth and development of children, learning ability, social adjustment, work efficiency, and productivity of labor. It seems that many deaths from PEM occur as a result of outdated clinical practices, and an improving of these practices appears to be essential to reduce this rate of morbidity and mortality [5]. PEM is responsible, directly or indirectly, for 54% of the 10.8 million deaths per year in children under 5 and contributes to
References
[1]
G. Zubin and C. Ee-Looi, “Protein energy malnutrition,” Pediatric Clinics of North America, vol. 56, no. 5, pp. 1055–1068, 2009.
[2]
J. R. Coura and J. C. P. Dias, “Epidemiology, control and surveillance of Chagas disease—100 years after its discovery,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 1, pp. 31–40, 2009.
[3]
M. Bl?ssner and M. De Onis, Malnutrition: Quantifying the Health Impact at National and Local Levels, World Health Organization, Geneva, Switzerland, 2005.
[4]
World Health Organization, “New global effort to eliminate Chagas disease,” 2007, http://www.who.int/mediacentre/news/releases/2007/pr36/en/index.html.
[5]
S. A. Akuyam, “A review of some metabolic changes in protein-energy malnutrition,” The Nigerian Postgraduate Medical Journal, vol. 14, no. 2, pp. 155–162, 2007.
[6]
A. L. Sawaya, “Desnutri??o: consequências em longo prazo e efeitos da recupera??o nutricional,” Estudos Avancados, vol. 20, no. 58, pp. 147–158, 2006.
[7]
A. M. Pablo, M. A. Izaga, and L. A. Alday, “Assessment of nutritional status on hospital admission: nutritional scores,” European Journal of Clinical Nutrition, vol. 57, no. 7, pp. 824–831, 2003.
[8]
H. Singh, K. Watt, R. Veitch, M. Cantor, and D. R. Duerksen, “Malnutrition is prevalent in hospitalized medical patients: are housestaff identifying the malnourished patient?” Nutrition, vol. 22, no. 4, pp. 350–354, 2006.
[9]
J. W. Bavelaar, C. D. Otter, A. A. van Bodegraven, A. Thijs, and M. A. E. van Bokhorst-de van der Schueren, “Diagnosis and treatment of (disease-related) in-hospital malnutrition: the performance of medical and nursing staff,” Clinical Nutrition, vol. 27, no. 3, pp. 431–438, 2008.
[10]
G. Malafaia, “Protein-energy malnutrition as an aggravating condition for the health of hospitalized patients,” Arquivos Brasileiros de Ciências da Saúde, vol. 34, pp. 101–107, 2009.
[11]
L. Allen, B. Benoist, O. Dary, and R. Hurrell, Guidelines on Food Fortification with Micronutrients, World Health Organization, Geneva, Switzerland, 2006.
[12]
J. L. Ambrus Sr. and J. L. Ambrus Jr., “Nutrition and infectious diseases in developing countries and problems of acquired immunodeficiency syndrome,” Experimental Biology and Medicine, vol. 229, no. 6, pp. 464–472, 2004.
[13]
D. Macallan, “Malnutrition and infection,” Medicine, vol. 33, no. 3, pp. 14–16, 2005.
[14]
U. E. Schaible and S. H. E. Kaufmann, “Malnutrition and infection: complex mechanisms and global impacts,” PLoS Medicine, vol. 4, no. 5, article e115, pp. 0806–0812, 2007.
[15]
N. W. Solomons, “Malnutrition and infection: an update,” British Journal of Nutrition, vol. 98, no. 1, pp. S5–S10, 2007.
[16]
P. Katona and J. Katona-Apte, “The interaction between nutrition and infection,” Clinical Infectious Diseases, vol. 46, no. 10, pp. 1582–1588, 2008.
[17]
R. Rakotoarimanana, “Nutrition and infection,” Revue Medicale Suisse, vol. 5, no. 220, pp. 975–978, 2009.
[18]
J. R. Koethe and D. C. Heimburger, “Nutritional aspects of HIV-associated wasting in sub-Saharan Africa,” American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 1138S–1142S, 2010.
[19]
K. Gupta, R. Gupta, A. Atreja, M. Verma, and S. Vishvkarma, “Tuberculosis and nutrition,” Lung India, vol. 26, no. 1, pp. 9–16, 2009.
[20]
World Health Organization (WHO), “Malaria and malnutrition. WHO/RBM Consultation—Best practices and lessons learnt from implementing malaria control in complex emergencies in Africa 2000–2004,” 2005, http://www.who.int/malaria/publications/atoz/malaria_and_malnutrition/en/index.html.
[21]
G. M. Anstead, B. Chandrasekar, W. Zhao, J. Yang, L. E. Perez, and P. C. Melby, “Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection,” Infection and Immunity, vol. 69, no. 8, pp. 4709–4718, 2001.
[22]
G. Malafaia, T. D. Serafim, M. E. Silva, M. L. Pedrosa, and S. A. Rezende, “Protein-energy malnutrition decreases immune response to Leishmania chagasi vaccine in BALB/c mice,” Parasite Immunology, vol. 31, no. 1, pp. 41–49, 2009.
[23]
T. D. Serafim, G. Malafaia, M. E. Silva, M. L. Pedrosa, and S. A. Rezende, “Immune response to Leishmania (Leishmania) chagasi infection is reduced in malnourished BALB/c mice,” Memorias do Instituto Oswaldo Cruz, vol. 105, no. 6, pp. 811–817, 2010.
[24]
A. L. De Andrade and F. Zicker, “Chronic malnutrition and Trypanosoma cruzi infection in children,” Journal of Tropical Pediatrics, vol. 41, no. 2, pp. 112–115, 1995.
[25]
F. Guhl, C. Jaramillo, G. A. Vallejo et al., “Isolation of Trypanosoma cruzi DNA in 4,000-year-old mummified human tissue from northern Chile,” American Journal of Physical Anthropology, vol. 108, no. 4, pp. 625–635, 1999.
[26]
A. A. Nóbrega, M. H. Garcia, E. Tatto et al., “Oral transmission of chagas disease by consumption of A?aí palm fruit, Brazil,” Emerging Infectious Diseases, vol. 15, no. 4, pp. 653–655, 2009.
[27]
R. Sathler-Avelar, D. M. Vitelli-Avelar, A. Teixeira-Carvalho, and O. A. Martins-Filho, “Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 1, supplement, pp. 246–251, 2009.
[28]
J. R. Coura, “Epidemiologic determinants of Chagas' disease in Brazil: the infection, the disease and its morbidity,” Memorias do Instituto Oswaldo Cruz, vol. 83, pp. 392–402, 1988.
[29]
A. M. Macedo and S. D. J. Pena, “Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease,” Parasitology Today, vol. 14, no. 3, pp. 119–124, 1998.
[30]
S. G. Andrade, R. F. Campos, K. S. Castro Sobral, J. B. Magalh?es, R. S. Pereira Guedes, and M. L. Guerreiro, “Reinfections with strains of Trypanosoma cruzi, of different biodemes as a factor of aggravation of myocarditis and myositis in mice,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 39, no. 1, pp. 1–8, 2006.
[31]
A. R. L. Teixeira, R. J. Nascimento, and N. R. Sturm, “Evolution and pathology in Chagas disease—a review,” Memorias do Instituto Oswaldo Cruz, vol. 101, no. 5, pp. 463–491, 2006.
[32]
J. R. Coura, “Chagas disease: what is known and what is needed—a background article,” Memorias do Instituto Oswaldo Cruz, vol. 102, no. 1, pp. 113–122, 2007.
[33]
M. D. L. Higuchi, L. A. Benvenuti, M. M. Reis, and M. Metzger, “Pathophysiology of the heart in Chagas' disease: current status and new developments,” Cardiovascular Research, vol. 60, no. 1, pp. 96–107, 2003.
[34]
A. Moncayo and M. I. Ortiz Yanine, “An update on Chagas disease (human American trypanosomiasis),” Annals of Tropical Medicine and Parasitology, vol. 100, no. 8, pp. 663–677, 2006.
[35]
P. V. A. Dos Santos, E. Roffê, H. C. Santiago et al., “Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules,” Microbes and Infection, vol. 3, no. 12, pp. 971–984, 2001.
[36]
A. Talvani, C. S. Ribeiro, J. C. S. Aliberti et al., “Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi,” Microbes and Infection, vol. 2, no. 8, pp. 851–866, 2000.
[37]
A. Talvani, M. O. C. Rocha, L. S. Barcelos, Y. M. Gomes, A. L. Ribeiro, and M. M. Teixeira, “Elevated concentrations of CCL2 and tumor necrosis factor-α in chagasic cardiomyopathy,” Clinical Infectious Diseases, vol. 38, no. 7, pp. 943–950, 2004.
[38]
A. Talvani, M. O. C. Rocha, A. L. Ribeiro, R. Correa-Oliveira, and M. M. Teixeira, “Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease,” Journal of Infectious Diseases, vol. 189, no. 2, pp. 214–220, 2004.
[39]
N. S. Scrimshaw, C. E. Taylor, and J. E. Gordon, “Interactions of nutrition and infection,” Monograph Series. World Health Organization, vol. 57, pp. 3–329, 1968.
[40]
G. Malafaia, “Efeitos das deficiências de ferro e zinco no sistema imune,” Revista Pesquisa & Pós-Gradua??o, vol. 8, pp. 5–9, 2007.
[41]
C. J. Field, I. R. Johnson, and P. D. Schley, “Nutrients and their role in host resistance to infection,” Journal of Leukocyte Biology, vol. 71, no. 1, pp. 16–32, 2002.
[42]
C. R. S. Machado, T. Moraes-Santos, and A. B. M. Machado, “Cardiac noradrenalin in relation to protein malnutrition in chronic experimental Chagas' disease in the rat,” American Journal of Tropical Medicine and Hygiene, vol. 33, no. 5, pp. 835–838, 1984.
[43]
N. G. Gomes, F. E. Pereira, G. C. Domingues, and J. R. Alves, “Effects of severe protein restriction in levels of parasitemia and in mortality of mice acutely infected with Trypanosoma cruzi,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 27, no. 1, pp. 19–24, 1994.
[44]
M. Carlomagno, G. Leer, M. Esteva, D. Hansen, and E. L. Segura, “Role of protein deficiency on the course of Trypanosoma cruzi infection and on the degree of protection conferred by a flagellar fraction,” Journal of Nutritional Immunology, vol. 4, no. 4, pp. 37–45, 1996.
[45]
I. P. Cintra, M. E. Silva, M. E. C. Silva et al., “Influence of dietary protein content on Trypanosoma cruzi infection in germfree and conventional mice,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 40, no. 6, pp. 355–362, 1998.
[46]
R. J. Earlam, “Gastrointestinal aspects of Chagas' disease,” The American Journal of Digestive Diseases, vol. 17, no. 6, pp. 559–571, 1972.
[47]
G. M. Anstead, B. Chandrasekar, Q. Zhang, and P. C. Melby, “Multinutrient undernutrition dysregulates the resident macrophage proinflammatory cytokine network, nuclear factor-κB activation, and nitric oxide production,” Journal of Leukocyte Biology, vol. 74, no. 6, pp. 982–991, 2003.
[48]
M. Abe, F. Akbar, B. Matsuura, N. Horiike, and M. Onji, “Defective antigen-presenting capacity of murine dendritic cells during starvation,” Nutrition, vol. 19, no. 3, pp. 265–269, 2003.
[49]
G. T. Keusch and M. J. Farthing, “Nutrition and infection,” Annual Review of Nutrition, vol. 6, pp. 131–154, 1986.
[50]
G. T. Keusch, J. J. Urrutia, O. Guerrero, G. Castaneda, and H. Smeth Jr., “Serum opsonic activity in acute protein-calorie malnutrition,” Bulletin of the World Health Organization, vol. 59, pp. 923–929, 1981.
[51]
R. K. Chandra, “Serum complement and immunoconglutinin in malnutrition,” Archives of Disease in Childhood, vol. 50, no. 3, pp. 225–229, 1975.
[52]
P. Scott, “The role of natural killer cells in host-parasite interactions,” Current Opinion in Immunology, vol. 7, no. 1, pp. 34–40, 1995.
[53]
F. Cardillo, F. Q. Cunha, W. M. S. C. Tamashiro, M. Russo, S. B. Garcia, and J. Mengel, “NK 1.1+ Cells and T-cell activation in euthymic and thymectomized C57B1/6 mice during acute Trypanosoma cruzi infection,” Scandinavian Journal of Immunology, vol. 55, no. 1, pp. 96–104, 2002.
[54]
F. Cardillo, J. C. Voltarelli, S. G. Reed, and J. S. Silva, “Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells,” Infection and Immunity, vol. 64, no. 1, pp. 128–134, 1996.
[55]
I. Sugawara, H. Yamada, and S. Mizuno, “BCG vaccination enhances resistance to M. tuberculosis infection in guinea pigs fed a low casein diet,” Tohoku Journal of Experimental Medicine, vol. 211, no. 3, pp. 259–268, 2007.
[56]
G. T. Keusch, J. R. Cruz, and B. Torun, “Immature circulating lymphocytes in severely malnourished Guatemalan children,” Journal of Pediatric Gastroenterology and Nutrition, vol. 6, no. 2, pp. 265–270, 1987.
[57]
W. Savino, M. C. Postel-Vinay, S. Smaniotto, and M. Dardenne, “The thymus gland: a target organ for growth hormone,” Scandinavian Journal of Immunology, vol. 55, no. 5, pp. 442–452, 2002.
[58]
B. Woodward, “Protein, calories, and immune defenses,” Nutrition Reviews, vol. 56, no. 1, pp. S84–S92, 1998.
[59]
C. O. Enwonwu, “Complex interactions between malnutrition, infection and immunity: relevance to HIV/AIDS infection,” Nigerian Journal of Clinical and Biomedical Research, vol. 1, pp. 6–14, 2006.
[60]
O. Nájera, C. González, G. Toledo et al., “CD45RA and CD45RO isoforms in infected malnourished and infected well-nourished children,” Clinical and Experimental Immunology, vol. 126, no. 3, pp. 461–465, 2001.
[61]
O. Nájera, C. González, G. Toledo, L. López, and R. Ortiz, “Flow cytometry study of lymphocyte subsets in malnourished and well-nourished children with bacterial infections,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 3, pp. 577–580, 2004.
[62]
L. Rodríguez, C. González, L. Flores, L. Jiménez-Zamudio, J. Graniel, and R. Ortiz, “Assessment by flow cytometry of cytokine production in malnourished children,” Clinical and Diagnostic Laboratory Immunology, vol. 12, no. 4, pp. 502–507, 2005.
[63]
B. Woodward, L. Hillyer, and K. Hunt, “T cells with a quiescent phenotype (CD45RA+) are overabundant in the blood and involuted lymphoid tissues in wasting protein and energy deficiencies,” Immunology, vol. 96, no. 2, pp. 246–253, 1999.
[64]
S. J. M. Ten Bruggencate, L. M. Hillyer, and B. D. Woodward, “The proportion of CD45RA+CD62L+ (quiescent-phenotype) T cells within the CD8+ subset increases in advanced weight loss in the protein- or energy-deficient weanling mouse,” Journal of Nutrition, vol. 131, no. 12, pp. 3266–3269, 2001.
[65]
T. R. Neyestani and B. Woodward, “Blood concentrations of Th2-type immunoglobulins are selectively increased in weanling mice subjected to acute malnutrition,” Experimental Biology and Medicine, vol. 230, no. 2, pp. 128–134, 2005.
[66]
L. Monjour, F. Bourdillon, A. M. Korinek et al., “Humoral immunity, 5 years after anti-tetanus vaccination, in a group of malaria-infected and malnourished African children,” Pathologie Biologie, vol. 36, no. 3, pp. 235–239, 1988.
[67]
B. M. Greenwood, A. M. Bradley-Moore, and A. K. Bradley, “The immune response to vaccination in undernourished and well-nourished Nigerian children,” Annals of Tropical Medicine and Parasitology, vol. 80, no. 5, pp. 537–544, 1986.
[68]
L. E. Caulfield, M. de Onis, M. Bl?ssner, and R. E. Black, “Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles,” The American journal of clinical nutrition, vol. 80, no. 1, pp. 193–198, 2004.
[69]
J. R. Mora, M. Iwata, and U. H. Von Andrian, “Vitamin effects on the immune system: vitamins A and D take centre stage,” Nature Reviews Immunology, vol. 8, no. 9, pp. 685–698, 2008.
[70]
R. G. Yaeger and O. N. Miller, “Effect of malnutrition on susceptibility of rats to Trypanosoma cruzi. I. Thiamine deficiency,” Experimental Parasitology, vol. 9, no. 3, pp. 215–222, 1960.
[71]
R. G. Yaeger and O. N. Miller, “Effect of malnutrition on susceptibility of rats to Trypanosoma cruzi. II. Riboflavin deficiency,” Experimental Parasitology, vol. 10, no. 2, pp. 227–231, 1960.
[72]
R. G. Yaeger and O. N. Miller, “Effect of malnutrition on susceptibility of rats to Trypanosoma cruzi. III. Pantothenate deficiency,” Experimental Parasitology, vol. 10, no. 2, pp. 232–237, 1960.
[73]
R. G. Yaeger and O. N. Miller, “Effect of malnutrition on susceptibility of rats to Trypanosoma cruzi. IV. Pyridoxine deficiency,” Experimental Parasitology, vol. 10, no. 2, pp. 238–244, 1960.
[74]
R. G. Yaeger and O. N. Miller, “Effect of malnutrition on susceptibility of rats to Trypanosoma cruzi. V. Vitamin A deficiency,” Experimental Parasitology, vol. 14, no. 1, pp. 9–14, 1963.
[75]
D. Lonsdale and R. J. Shamberger, “Red cell transketolase as an indicator of nutritional deficiency,” American Journal of Clinical Nutrition, vol. 33, no. 2, pp. 205–211, 1980.
[76]
M. K. Horwitt, E. Liebert, O. Kriesler, and P. Wittman, “Investigations of human requirements for B-complex vitamins. Bulletin of the National Research Council. Report of the Committee on Nutritional Aspects of Ageing, Food and Nutrition Board, Division of Biology and Agriculture,” National Academy of Sciences, Washington, DC, USA, 1948.
[77]
K. Inouye and E. katsura, “Clinical signs and metabolism of beriberi patients,” in Review of Japanese Literature on Beriberi and Thiamine, A. N. Shum and E. Katsura, Eds., pp. 29–63, Igaku Shoin Ltd., Tokyo, Japan, 2nd edition, 1965.
[78]
B. S. Platt, “Thiamine deficiency in human beriberi and in Wernicke's encephalopathy,” in Thiamine Deficiency, G. E. W. Wolstenholme and M. O'Connor, Eds., pp. 135–143, Little Brown & Co., Boston, Mass, USA, 1967.
[79]
R. D. Williams, H. L. Mason, M. H. Power, and R. M. Wilder, “Induced thiamine (Vitamin Bl) deficiency in man; relation of depletion of thiamine to development of biochemical defect and of polyneuropathy,” Archives of Internal Medicine, vol. 71, pp. 38–53, 1943.
[80]
Z. J. Ke and G. E. Gibson, “Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism,” Neurochemistry International, vol. 45, no. 2-3, pp. 361–369, 2004.
[81]
A. Ba, “Metabolic and structural role of thiamine in nervous tissues,” Cellular and Molecular Neurobiology, vol. 28, no. 7, pp. 923–931, 2008.
[82]
A. S. Hazell and R. F. Butterworth, “Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation,” Alcohol and Alcoholism, vol. 44, no. 2, pp. 141–147, 2009.
[83]
G. Scalabrino, “Vitamin-regulated cytokines and growth factors in the CNS and elsewhere,” Journal of Neurochemistry, vol. 111, no. 6, pp. 1309–1326, 2009.
[84]
L. C. Rall and S. N. Meydani, “Vitamin B and immune competence,” Nutrition Reviews, vol. 51, no. 8, pp. 217–225, 1993.
[85]
C. B. Stephensen, “Vitamin A, infection, and immune function,” Annual Review of Nutrition, vol. 21, pp. 167–192, 2001.
[86]
D. Mucida, Y. Park, and H. Cheroutre, “From the diet to the nucleus: vitamin A and TGF-β join efforts at the mucosal interface of the intestine,” Seminars in Immunology, vol. 21, no. 1, pp. 14–21, 2009.
[87]
L. S. C. Carvalho, E. R. S. Camargos, C. T. Almeida et al., “Vitamin E deficiency enhances pathology in acute Trypanosoma cruzi-infected rats,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 11, pp. 1025–1031, 2006.
[88]
S. Moriguchi, H. Miwa, M. Okamura, K. Maekawa, Y. Kishino, and K. Maeda, “Vitamin E is an important factor in T cell differentiation in thymus of F344 rats,” Journal of Nutritional Science and Vitaminology, vol. 39, no. 5, pp. 451–463, 1993.
[89]
A. B. Younes-Chennoufi, G. Said, H. Eisen, A. Durand, and M. Hontebeyrie-Joskowicz, “Cellular immunity to Trypanosoma cruzi is mediated by helper T cells (CD4+),” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 82, no. 1, pp. 84–89, 1988.
[90]
R. L. Tarleton, J. Sun, L. Zhang, and M. Postan, “Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease,” Infection and Immunity, vol. 62, no. 5, pp. 1820–1829, 1994.
[91]
K. S. Mikhail and E. C. Rowland, “Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection,” Journal of Parasitology, vol. 76, no. 5, pp. 690–697, 1990.
[92]
A. M. T. Amarakoon, P. S. Tappia, and R. F. Grimble, “Endotoxin induced production of interleukin-6 is enhanced by vitamin E deficiency and reduced by black tea extract,” Inflammation Research, vol. 44, no. 7, pp. 301–305, 1995.
[93]
M. A. Beck, “Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency,” Journal of Nutrition, vol. 127, no. 5, pp. 966S–970S, 1997.
[94]
R. F. Grimble, “Effect of antioxidative vitamins on immune function with clinical applications,” International Journal for Vitamin and Nutrition Research, vol. 67, no. 5, pp. 312–320, 1997.
[95]
F. Marra, R. DeFranco, C. Grappone et al., “Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E,” Journal of Investigative Medicine, vol. 47, no. 1, pp. 66–75, 1999.
[96]
G. Rimbach, A. M. Minihane, J. Majewicz et al., “Regulation of cell signalling by vitamin E,” Proceedings of the Nutrition Society, vol. 61, no. 4, pp. 415–425, 2002.
[97]
A. Dhur, P. Galan, and S. Hercberg, “Iron status, immune capacity and resistance to infections,” Comparative Biochemistry and Physiology. Part A, vol. 94, no. 1, pp. 11–19, 1989.
[98]
S. J. Oppenheimer, “Iron and its relation to immunity and infectious disease,” Journal of Nutrition, vol. 131, no. 2, pp. 616S–633S, 2001.
[99]
S. Hughes and P. Kelly, “Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites,” Parasite Immunology, vol. 28, no. 11, pp. 577–588, 2006.
[100]
R. G. Lalonde and B. E. Holbein, “Role of iron in Trypanosoma cruzi infection of mice,” Journal of Clinical Investigation, vol. 73, no. 2, pp. 470–476, 1984.
[101]
M. L. Pedrosa, M. E. Silva, M. E. Silva, M. E. C. Silva, J. R. Nicoli, and E. C. Vieira, “The effect of iron deficiency and iron overload on the evolution of Chagas disease produced by three strains of Trypanosoma cruzi in CFW mice,” Comparative Biochemistry and Physiology A, vol. 97, no. 2, pp. 235–243, 1990.
[102]
M. L. Pedrosa, J. R. Nicoli, M. E. Silva et al., “The effect of iron nutritional status on Trypanosoma cruzi infection in germfree and conventional mice,” Comparative Biochemistry and Physiology, vol. 106, no. 4, pp. 813–821, 1993.
[103]
E. R. P. Lala, M. H. Andó, L. Zalloum et al., “Trypanosoma cruzi: different methods of data analysis to evaluate the genetics-biology relationship,” Experimental Parasitology, vol. 123, no. 2, pp. 173–181, 2009.
[104]
D. M. Santos, T. A. F. Martins, I. S. Caldas et al., “Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection,” Acta Tropica, vol. 113, no. 2, pp. 134–138, 2010.
[105]
J. M. Arantes, M. L. Pedrosa, H. R. Martins et al., “Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice,” Experimental Parasitology, vol. 117, no. 1, pp. 43–50, 2007.
[106]
A. F. Francisco, P. M. de Abreu Vieira, J. M. Arantes et al., “Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice,” Experimental Parasitology, vol. 120, no. 4, pp. 314–319, 2008.
[107]
D. Mafra and S. M. F. Cozzolino, “The importance of zinc in human nutritionImportancia do zinco na nutri??o humana,” Revista de Nutricao, vol. 17, no. 1, pp. 79–87, 2004.
[108]
H. Haase, E. Mocchegiani, and L. Rink, “Correlation between zinc status and immune function in the elderly,” Biogerontology, vol. 7, no. 5-6, pp. 421–428, 2006.
[109]
A. H. Shankar and A. S. Prasad, “Zinc and immune function: the biological basis of altered resistance to infection,” American Journal of Clinical Nutrition, vol. 68, no. 2, pp. 447S–463S, 1998.
[110]
P. J. Fraker, L. E. King, T. Laakko, and T. L. Vollmer, “The dynamic link between the integrity of the immune system and zinc status,” Journal of Nutrition, vol. 130, supplement 5, pp. 1452–1456, 2000.
[111]
W. B. Pratt and D. O. Toft, “Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery,” Experimental Biology and Medicine, vol. 228, no. 2, pp. 111–133, 2003.
[112]
P. J. Delves and I. M. Roitt, “The immune system. First of two parts,” New England Journal of Medicine, vol. 343, no. 1, pp. 37–49, 2000.
[113]
V. Braz?o, M. D. V. Filipin, L. C. Caetano, M. P. A. Toldo, L. N. Caetano, and J. C. D. Prado, “Trypanosoma cruzi: the effects of zinc supplementation during experimental infection,” Experimental Parasitology, vol. 118, no. 4, pp. 549–554, 2008.
[114]
V. Braz?o, L. C. Caetano, M. Del Vecchio Filipin, M. Paula Alonso Toldo, L. N. Caetano, and J. C. do Prado, “Zinc supplementation increases resistance to experimental infection by Trypanosoma cruzi,” Veterinary Parasitology, vol. 154, no. 1-2, pp. 32–37, 2008.
[115]
V. Braz?o, L. C. Caetano, M. D. Vecchio Filipin, F. H. Santello, M. P. Alonso Toldo, and J. C. do Prado, “Trypanosoma cruzi: the effects of zinc supplementation in the immune response during the course of experimental disease,” Experimental Parasitology, vol. 121, no. 1, pp. 105–109, 2009.
[116]
V. Braz?o, F. H. Santello, L. C. Caetano, M. Del Vecchio Filipin, M. Paula Alonso Toldo, and J. C. do Prado, “Immunomodulatory effects of zinc and DHEA on the Th-1 immune response in rats infected with Trypanosoma cruzi,” Immunobiology, vol. 215, no. 5, pp. 427–434, 2010.
[117]
J. F. Gon?alves-Neto, M. P. Alonso Toldo, C. D. Santos, J. C. do Prado Júnior, C. Fonseca, and S. Albuquerque, “Effect of zinc supplementation in pregnant mice during experimental Trypanosoma cruzi infection,” Research in Veterinary Science, vol. 90, no. 2, pp. 269–274, 2011.
[118]
A. T. Diplock, “Trace elements in human health with special reference to selenium,” American Journal of Clinical Nutrition, vol. 45, no. 5, pp. 1313–1322, 1987.
[119]
N. W. Solomons and M. Ruz, “Trace element requirements in humans: an update,” Journal of Trace Elements in Experimental Medicine, vol. 11, no. 2-3, pp. 177–195, 1998.
[120]
M. P. Rayman, “The importance of selenium to human health,” Lancet, vol. 356, no. 9225, pp. 233–241, 2000.
[121]
J. Nève, “Selenium as a risk factor for cardiovascular diseases,” Journal of Cardiovascular Risk, vol. 3, no. 1, pp. 42–47, 1996.
[122]
M. T. Rivera, A. P. De Souza, A. H. M. Moreno et al., “Progressive Chagas' cardiomyopathy is associated with low selenium levels,” American Journal of Tropical Medicine and Hygiene, vol. 66, no. 6, pp. 706–712, 2002.
[123]
A. P. De Souza, G. M. De Oliveira, J. Nève et al., “Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice,” Experimental Parasitology, vol. 101, no. 4, pp. 193–199, 2002.
[124]
R. M. Gomez, M. E. Solana, and O. A. Levander, “Host selenium deficiency increases the severity of chronic inflammatory myopathy in Trypanosoma cruzi-inoculated mice,” Journal of Parasitology, vol. 88, no. 3, pp. 541–547, 2002.
[125]
A. P. De Souza, G. M. De Oliveira, J. Vanderpas, S. L. De Castro, M. T. Rivera, and T. C. Araújo-Jorge, “Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection,” Parasitology Research, vol. 91, no. 1, pp. 51–54, 2003.
[126]
A. P. De Souza, R. Sieberg, H. Li et al., “The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection,” Parasitology Research, vol. 106, no. 6, pp. 1293–1298, 2010.
[127]
A. P. De Souza, L. A. Jelicks, H. B. Tanowitz et al., “The benefits of using selenium in the treatment of Chagas disease: Prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice,” Memorias do Instituto Oswaldo Cruz, vol. 105, no. 6, pp. 746–751, 2010.